Robotic pharmacies potential and limitations of artificial intelligence: a case study
by Mounir M. El Khatib; Gouher Ahmed
International Journal of Business Innovation and Research (IJBIR), Vol. 23, No. 3, 2020

Abstract: This study evaluates the robotic pharmacies as one of the latest smart technologies adopted in the hospitals of the United Arab Emirates, an evolving global healthcare hub. Three government hospitals were investigated with the 'makes' of same robot pharmacy Omnicell German Co. and compared with the robot pharmacy named UCSF Medical Center pharmacy being used in San Francisco to investigate the differences if any between the two robots. The findings reveal robotic pharmacy results in the cost and error reduction, decrease in patient waiting time and increase in service delivery efficiency. Artificial intelligence (AI) can provide an opportunity for more significant benefits to the robotic pharmacy. The study suggests that it is essential to take substantive steps towards the enhancement of AI in robotic pharmacy, which the authorities in the UAE, known for its technological dynamism, may take due cognizance in the course of time.

Online publication date: Tue, 03-Nov-2020

The full text of this article is only available to individual subscribers or to users at subscribing institutions.

 
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.

Pay per view:
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.

Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Business Innovation and Research (IJBIR):
Login with your Inderscience username and password:

    Username:        Password:         

Forgotten your password?


Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.

If you still need assistance, please email subs@inderscience.com